Liveramp Holdings Inc
SWB:XIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Liveramp Holdings Inc
SWB:XIM
|
US |
|
T
|
TotalEnergies SE
F:TOTB
|
FR |
|
M
|
Medios AG
XMUN:ILM1
|
DE |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
Wall St Price Targets
XIM Price Targets Summary
Liveramp Holdings Inc
According to Wall Street analysts, the average 1-year price target for XIM is 34.61 EUR with a low forecast of 26.32 EUR and a high forecast of 45.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XIM's stock price target?
Price Target
34.61
EUR
According to Wall Street analysts, the average 1-year price target for XIM is 34.61 EUR with a low forecast of 26.32 EUR and a high forecast of 45.6 EUR.
What is the Revenue forecast for Liveramp Holdings Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Liveramp Holdings Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 9%.
What is the Operating Income forecast for Liveramp Holdings Inc?
Projected CAGR
72%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 2 years is 72%.
What is the Pre-Tax Income forecast for Liveramp Holdings Inc?
Projected CAGR
70%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 2 years is 70%.
What is the Net Income forecast for Liveramp Holdings Inc?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 2 years is 21%.
